Sequenom Inc. (SQNM) CFO Paul W Hawran buys 5,000 Shares

Author's Avatar
Mar 04, 2009
CFO of Sequenom Inc. (SQNM, Financial) Paul W Hawran buys 5,000 shares of SQNM on 03/04/2009 at an average price of $13.45 a share.

Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health agriculture and livestock. These variations are the differences between individuals including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system an accurate cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds. Sequenom Inc. has a market cap of $972.03 million; its shares were traded at around $13.032 with and P/S ratio of 20.62.

Recent Trades of Sequenom Inc. by CEO:
  • Buy: President and CEO, Director Harry Stylli bought 10,000 shares of SQNM stock on 02/13/2009 at the average price of $16.5; the price of the stock has decreased by 21.02% since.



Recent Trades of Sequenom Inc. by CFO:
  • Buy: CFO Paul W Hawran bought 5,000 shares of SQNM stock on 03/04/2009 at the average price of $13.45; the price of the stock has decreased by 3.11% since.



Recent Trades of Sequenom Inc. by Directors and Officers:
  • Buy: Director John A Fazio bought 500 shares of SQNM stock on 02/13/2009 at the average price of $16.95; the price of the stock has decreased by 23.12% since.

  • Buy: 10% Owner Capital Investments Ridgeback bought 325,000 shares of SQNM stock on 09/10/2008 at the average price of $19.47; the price of the stock has decreased by 33.07% since.

  • Sell: VP, Business Development Karsten Schmidt sold 5,000 shares of SQNM stock on 12/24/2008 at the average price of $19.88; the price of the stock has decreased by 34.45% since.

  • Sell: Director Ernst-gunter Afting sold 6,300 shares of SQNM stock on 12/09/2008 at the average price of $16.52; the price of the stock has decreased by 21.11% since.